Louis Tartaglia, MD
Sleep Medicine · Maumee, OHNPI 1811978455
Payments from drug & device makers
Across 717 payments — averaging $437.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$202K
- Axsome Therapeutics, Inc.$43K
- Avadel CNS Pharmaceuticals, LLC$34K
- Harmony Biosciences LLC$31K
- United Therapeutics Corporation$513
- Idorsia Pharmaceuticals US Inc$291
- plus $3K from 28 others
What the payments were for
- Consulting fees$49,06116%
- Speaking & faculty fees$207,22166%
- Travel & lodging$40,34113%
- Food & beverage$16,5635%
- Education$4960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 278 | $202,085 |
| Axsome Therapeutics, Inc. | 111 | $42,879 |
| Avadel CNS Pharmaceuticals, LLC | 69 | $33,977 |
| Harmony Biosciences LLC | 91 | $31,186 |
| United Therapeutics Corporation | 30 | $513 |
| Idorsia Pharmaceuticals US Inc | 13 | $291 |
| Inspire Medical Systems, Inc. | 10 | $284 |
| Sanofi | 14 | $274 |
| Baxter Healthcare | 9 | $265 |
| Eisai Inc. | 4 | $252 |
| Boehringer Ingelheim | 9 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $171 |
| Merck | 9 | $158 |
| Regeneron Healthcare Solutions, Inc. | 6 | $123 |
| Bayer | 6 | $119 |
| Corcept Therapeutics | 1 | $115 |
| Insmed, Inc. | 6 | $107 |
| Arbor Pharmaceuticals, Inc. | 6 | $83 |
| Actelion Pharmaceuticals US, Inc. | 4 | $83 |
| GSK | 5 | $73 |
| Mylan Specialty L.p. | 4 | $72 |
| Grifols USA, LLC | 2 | $57 |
| Inogen, Inc. | 3 | $53 |
| Viatris Specialty LLC | 2 | $50 |
| Philips North America LLC | 3 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $33 |
| AstraZeneca | 2 | $29 |
| Covis Pharma GmbH | 2 | $24 |
| La Jolla Pharmaceutical Company | 1 | $19 |
| Fisher & Paykel Healthcare Inc | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Advanced Respiratory, Inc | 1 | $16 |
| Amgen | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$313,681 in reported general payments places this provider in the 95th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 62 | $1,174,394 |
| WakixPitolisant Hcl | 48 | $762,801 |
| SunosiSolriamfetol Hcl | 42 | $51,268 |
| HorizantGabapentin Enacarbil | 28 | $34,019 |
| BelsomraSuvorexant | 15 | $13,538 |
| ConcertaMethylphenidate Hcl | 11 | $9,278 |
| Armodafinil | 84 | $8,703 |
| Modafinil | 56 | $4,253 |
| Gabapentin | 377 | $4,165 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 33 | $3,518 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 64 | $2,364 |
| Ropinirole Hcl | 160 | $2,290 |
| Trazodone Hcl | 150 | $1,481 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 75 | $791 |
| Clonazepam | 104 | $636 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $31,186 | $762,80148 claims |
| Axsome Therapeutics, Inc.Sunosi | $42,879 | $51,26842 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $83 | $34,01928 claims |
| MerckBelsomra | $158 | $13,53815 claims |
| Johnson & JohnsonConcerta | $12 | $9,27811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 94 sleep medicine providers in Ohio.
Other sleep medicine in Maumee
- Asim RoyDublin$2.2M
- Nancy Foldvary-SchaeferCleveland$1.6M
- Shahrokh JavaheriCincinnati$404K
- John AndrefskyParma$147K
- Ulysses MagalangColumbus$143K
- Sally IbrahimCleveland$130K
- Anthony SuchoskiCincinnati$89K
- Shayla PullenCincinnati$71K
- Mansoor AhmedWestlake$62K
- Gautam SamadderColumbus$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.